Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

UPDATE 2-European shares rebound as Brexit trade deal progress overshadows virus worries

Published 12/22/2020, 06:05 PM
Updated 12/23/2020, 01:30 AM
© Reuters.
UK100
-
AMGN
-
AZN
-
SXRP
-
STOXX
-
SX8P
-
SX7P
-

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)
* Britain-EU rifts over fishing narrow
* U.S. Congress approves $892 bln pandemic aid package
* Tech stocks, banks lead broad-based gains in Europe
* AstraZeneca slips as asthma drug fails in late-stage trial

(Updates to close)
By Susan Mathew
Dec 22 (Reuters) - European shares posted their best day in
six weeks on Tuesday, rebounding from a sharp sell-off as
optimism around Brexit and U.S. stimulus helped to allay worries
of a further hit to the global economy from a new coronavirus
variant in Britain.
The pan-European STOXX 600 index .STOXX finished up 1.2%
on broad-based gains, recovering from a more than 2% slide in
the previous session, which was also its biggest one-day drop in
nearly two months.
The European Union is giving a "final push" in a bid to
strike a Brexit trade deal with Britain, its chief negotiator
said on Tuesday, with the two sides inching towards agreement on
fishing - a major sticking point - days before the end of
Britain's transition deal since it left the bloc.
"(The progress in fishing) highlights the willingness to
move towards something that will eventually break the current
deadlock," said Joshua Mahony, senior market analyst at online
trading platform IG.
Helping London's blue-chip index .FTSE reverse early
losses, data showed Britain's economic recovery from its
coronavirus crash was quicker than previously thought in the
third quarter. The index closed 0.6% higher, breaking a
three-day losing streak.
The losses were triggered by the emergence of a
fast-spreading new coronavirus variant in Britain, which has
forced wider lockdowns there and led countries around the world
to close their borders to the UK. The EU on Tuesday recommended
rolling back border closures to allow freight to resume.
"The COVID-led economic isolation of the UK (is) serving to
provide a heavy dose of reality of the kind of disruption that
could come if negotiators fail to agree a (Brexit trade) deal by
year-end," Mahony said.
Technology stocks .SX8P and Brexit-sensitive banks .SX7P
led the rebound in Europe, while materials stocks .SXPP lagged
as they tracked a decline in underlying commodity prices.
MET/L O/R
Meanwhile, U.S. President Donald Trump on Tuesday signed a
stopgap measure to fund U.S. agencies for another week after
Congress passed a long awaited $892 billion COVID-19 aid package
overnight.
AstraZeneca AZN.L was the biggest weight on the pan-region
index, down 1.5% after its experimental asthma drug developed
with U.S partner Amgen AMGN.O failed to meet the main goal of
a late-stage trial.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.